Structures by: Rangappa K. S.
Total: 46
5-Bromo-1,2,4-triazolo[1,5-<i>a</i>]pyrimidine
C5H3BrN4
IUCrData (2016) 1, 12 x161944
a=3.9511(4)Å b=14.3306(11)Å c=11.3670(10)Å
α=90° β=94.574(8)° γ=90°
1-(2'-Ethoxy-4'-fluoro-[1,1'-biphenyl]-4-yl)-4-phenyl-1<i>H</i>-1,2,3-triazole
C22H18FN3O
IUCrData (2016) 1, 10 x161712
a=24.392(3)Å b=5.9336(8)Å c=12.3651(16)Å
α=90° β=100.828(8)° γ=90°
5-(2-Ethoxy-4-fluorophenyl)-1,2,4-triazolo[1,5-<i>a</i>]pyrimidine
C13H11FN4O
IUCrData (2016) 1, 11 x161770
a=3.9166(3)Å b=16.6608(11)Å c=18.8096(14)Å
α=90° β=93.232(7)° γ=90°
Imidazole
C8H11ClN2O
Analytical Sciences: X-ray Structure Analysis Online (2003) 19, x31-x32
a=7.251Å b=13.195(1)Å c=9.835(1)Å
α=90° β=101.94° γ=90°
Imidazole
C8H11ClN2O
Analytical Sciences: X-ray Structure Analysis Online (2003) 19, x31-x32
a=7.251Å b=13.195(1)Å c=9.835(1)Å
α=90° β=101.94° γ=90°
C8H10IN3
C8H10IN3
Journal of the American Chemical Society (1996) 118, 4925-4930
a=8.973(1)Å b=6.542(1)Å c=17.092(1)Å
α=90° β=90° γ=90°
C10H12IN3
C10H12IN3
Journal of the American Chemical Society (1996) 118, 4925-4930
a=26.993(4)Å b=5.599(1)Å c=15.917(2)Å
α=90° β=105.44(1)° γ=90°
C14H11N3O
C14H11N3O
Organic & biomolecular chemistry (2020) 18, 14 2678-2684
a=5.4509(7)Å b=19.981(3)Å c=10.8572(16)Å
α=90.00° β=103.309(5)° γ=90.00°
C15H10FN7O
C15H10FN7O
New J. Chem. (2016)
a=15.3861(12)Å b=7.2041(7)Å c=15.4751(12)Å
α=90.00° β=117.318(4)° γ=90.00°
C35H36N2O6S2
C35H36N2O6S2
New J. Chem. (2015) 39, 11 8397
a=17.5740(17)Å b=8.9640(9)Å c=20.843(2)Å
α=90.00° β=106.682(4)° γ=90.00°
C30H26Br3O5
C30H26Br3O5
New J. Chem. (2015) 39, 11 8397
a=9.9779(11)Å b=11.5105(12)Å c=13.4027(14)Å
α=91.472(6)° β=107.929(6)° γ=109.296(6)°
C30H26BrClN2O3
C30H26BrClN2O3
New J. Chem. (2015) 39, 11 8397
a=9.5848(7)Å b=11.0031(8)Å c=14.0353(11)Å
α=87.764(2)° β=70.878(2)° γ=65.624(2)°
C24H18BrN2O
C24H18BrN2O
RSC Advances (2015) 5, 110 90408
a=18.750(2)Å b=6.8019(9)Å c=15.436(2)Å
α=90.00° β=94.233(7)° γ=90.00°
C23H16F3N3O3
C23H16F3N3O3
RSC Adv. (2016)
a=9.3819(12)Å b=8.0471(10)Å c=26.808(4)Å
α=90° β=93.592(7)° γ=90°
C19H13N3O2S
C19H13N3O2S
RSC Adv. (2016)
a=9.6224(12)Å b=14.7044(19)Å c=11.8502(16)Å
α=90.00° β=98.565(4)° γ=90.00°
C19H12FN3
C19H12FN3
RSC Adv. (2016) 6, 62 57154
a=12.6875(4)Å b=6.8467(2)Å c=33.0184(10)Å
α=90.00° β=95.813(2)° γ=90.00°
\ 1-(3-methylphenyl)-5-methylsulfonyl-3-[4-(trifluoromethyl)phenyl]-\ 4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine
C22H22F3N3O2S
Acta Crystallographica Section C (2017) 73, 3 298-304
a=13.8408(10)Å b=8.7145(6)Å c=18.0898(13)Å
α=90° β=106.470(2)° γ=90°
1-(4-Chlorophenyl)-5-methylsulfonyl-3-[4-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine
C21H19ClF3N3O2S
Acta Crystallographica Section C (2017) 73, 3 298-304
a=5.4468(2)Å b=11.4102(4)Å c=34.3009(9)Å
α=90° β=90° γ=90°
1-(4-Fluorophenyl)-5-methylsulfonyl-3-[4-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine
C21H19F4N3O2S
Acta Crystallographica Section C (2017) 73, 3 298-304
a=19.7282(6)Å b=9.7644(3)Å c=20.7157(7)Å
α=90° β=90° γ=90°
(<i>RS</i>)-7-Chloro-2-(2,5-dimethoxyphenyl)-2,3-dihydroquinazolin-4(1<i>H</i>)-one
C16H15ClN2O3
Acta Crystallographica Section E (2019) 75, 6 843-847
a=15.314(7)Å b=15.314(7)Å c=25.736(12)Å
α=90° β=90° γ=90°
6,7-Dimethoxy-2,4-diphenylquinoline
C23H19NO2
Acta Crystallographica Section E (2014) 70, 2 o165
a=8.7092(3)Å b=10.5639(3)Å c=20.3400(7)Å
α=85.6780(10)° β=79.3970(10)° γ=80.1340(10)°
[4-(4-Methoxyphenyl)-2-(pyridin-3-yl)-1,3-thiazol-5-yl][4-(trifluoromethyl)phenyl]methanone
C23H15F3N2O2S
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 9 o1434
a=19.4157(5)Å b=7.6564(2)Å c=27.4040(7)Å
α=90° β=90° γ=90°
1-(4-Methylphenylsulfonyl)-2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfanyl}-1<i>H</i>-1,3-benzimidazole
C23H20F3N3O3S2
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 12 o1846
a=9.1129(6)Å b=9.5116(6)Å c=13.7914(8)Å
α=90.978(3)° β=101.749(2)° γ=93.449(3)°
2-(Biphenyl-4-yl)-3-(4-methoxyphenyl)-1,3-thiazolidin-4-one
C22H19NO2S
Acta Crystallographica Section E (2005) 61, 7 o2315-o2317
a=6.2870(5)Å b=13.2480(9)Å c=22.2500(9)Å
α=90.00° β=90.00° γ=90.00°
6-Phenyl-5,6-dihydrobenzoimidazo[1,2-c]quinazoline
C20H15N3
Acta Crystallographica Section E (2005) 61, 10 o3249-o3251
a=11.5690(8)Å b=9.9150(7)Å c=14.3370(10)Å
α=90° β=114.086(4)° γ=90°
(Z)-3-(3,4-dimethoxyphenyl)-2-(4-methoxyphenyl)acrylonitrile
C18H17NO3
Acta Crystallographica Section E (2006) 62, 8 o3239-o3241
a=14.830(9)Å b=13.688(7)Å c=7.445(16)Å
α=90° β=91.724(2)° γ=90°
10-(2-Bromo-4,5-dimethoxy-benzyl) -7-chloro-5-cyclopropyl-9-methyl-5,10-dihydro-4,5,6,10-tetraaza-dibenzo [<i>a,d</i>]cyclohepten-11-one
C24H22BrClN4O3
Acta Crystallographica Section E (2006) 62, 11 o5110-o5111
a=9.0680(9)Å b=16.7840(9)Å c=16.1960(16)Å
α=90° β=107.260(2)° γ=90°
1-phenylsulfonyl-1H-1,2-4-triazole
C8H7N3O2S
Acta Crystallographica Section E (2006) 62, 12 o5893-o5895
a=11.395(14)Å b=5.045(3)Å c=17.698(19)Å
α=90° β=115.445(3)° γ=90°
2-(4-chlorophenyl)-3-phenyl-1,3-thiazolidin-4-one
C15H12ClNOS
Acta Crystallographica Section E (2007) 63, 3 o1457-o1458
a=9.7260(10)Å b=13.752(2)Å c=10.3970(10)Å
α=90° β=97.887(5)° γ=90°
[1-(4-Chloro-2-fluorophenylsulfonyl)piperidin-4-yl]diphenylmethanol
C24H23ClFNO3S
Acta Crystallographica Section E (2007) 63, 9 o3669-o3669
a=10.238(7)Å b=11.295(4)Å c=21.072(12)Å
α=90° β=115.481(2)° γ=90°
(2-Ethoxyphenyl)[4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl]methanone
C21H21FN2O3
Acta Crystallographica Section E (2007) 63, 2 o642-o643
a=7.029(6)Å b=9.851(7)Å c=14.120(2)Å
α=107.125(5)° β=94.622(5)° γ=100.513(5)°
1-Benzhydryl-4-(4-chlorophenylsulfonyl)piperazine
C23H23ClN2O2S
Acta Crystallographica Section E (2008) 64, 2 o358-o358
a=9.392(7)Å b=13.114(10)Å c=19.225(11)Å
α=90° β=113.645(3)° γ=90°
(Z)-2-(4-methoxyphenyl)-3-phenylacrylonitrile
C16H13NO
Acta Crystallographica Section E (2006) 62, 9 o3998-o4000
a=7.362(9)Å b=11.859(12)Å c=14.481(13)Å
α=89.658(6)° β=82.467(6)° γ=89.604(5)°
3-[4-(Dimethylamino)phenyl]-2-(4-methoxyphenyl)acrylonitrile
C18H18N2O
Acta Crystallographica Section E (2006) 62, 10 o4345-o4347
a=11.736(9)Å b=7.646(8)Å c=19.932(12)Å
α=90° β=123.379(5)° γ=90°
N-(2-Methylphenyl)-C-(3,4,5-trimethoxyphenyl)nitrone
C17H19NO4
Acta Crystallographica Section E (2006) 62, 11 o4793-o4795
a=7.532(8)Å b=8.256(9)Å c=12.872(13)Å
α=90° β=96.283(4)° γ=90°
<i>N</i>-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methoxybenzamide
C16H11F3N2O2
Acta Crystallographica Section E (2011) 67, 1 o198
a=15.117(2)Å b=13.907(2)Å c=14.5410(11)Å
α=90° β=107.360(8)° γ=90°
<i>N</i>-(4-cyano-3-(trifluromethyl)phenyl)-2-ethoxybenzamide
C17H13F3N2O2
Acta Crystallographica Section E (2010) 66, 7 o1533
a=10.5010(13)Å b=12.8830(16)Å c=11.6130(14)Å
α=90.00° β=101.653(6)° γ=90.00°
7-Chloro-5-cyclopropyl-9-methyl-5<i>H</i>-4,5,6,10- tetraazadibenzo[<i>a</i>,<i>d</i>]cyclohepten-11(10<i>H</i>)-one
C15H13ClN4O
Acta Crystallographica Section E (2011) 67, 6 o1445-o1446
a=12.7750(6)Å b=13.5870(7)Å c=16.4920(9)Å
α=90° β=90° γ=90°
2-(4-Chlorophenyl)-6-methyl-4-(3-methylphenyl)quinoline
C23H18ClN
Acta Crystallographica Section E (2012) 68, 11 o3250
a=7.982(3)Å b=17.921(6)Å c=12.478(4)Å
α=90° β=92.581(6)° γ=90°
C21H15ClN2
C21H15ClN2
Journal of Organic Chemistry (2013) 78, 4960-4973
a=13.053(5)Å b=5.964(5)Å c=22.400(5)Å
α=90.00° β=104.204(5)° γ=90.00°
C20H15N3O0
C20H15N3O0
Journal of Organic Chemistry (2013) 78, 4960-4973
a=10.5700(6)Å b=12.2810(13)Å c=12.1750(13)Å
α=90.00° β=94.429(7)° γ=90.00°
C21H15ClN2
C21H15ClN2
Journal of Organic Chemistry (2013) 78, 4960-4973
a=19.0435(7)Å b=5.8998(2)Å c=15.7160(5)Å
α=90.00° β=111.362(2)° γ=90.00°
C23H18N4
C23H18N4
Journal of Organic Chemistry (2013) 78, 4960-4973
a=8.3176(5)Å b=9.1581(6)Å c=13.6637(9)Å
α=79.165(3)° β=74.483(3)° γ=68.131(3)°
C20H15N3O0
C20H15N3O0
Journal of Organic Chemistry (2013) 78, 4960-4973
a=27.620(3)Å b=7.8020(8)Å c=16.1390(12)Å
α=90.00° β=111.655(5)° γ=90.00°
C23H18N4
C23H18N4
Journal of Organic Chemistry (2013) 78, 4960-4973
a=9.3639(16)Å b=10.2100(18)Å c=10.8034(18)Å
α=72.267(4)° β=69.494(3)° γ=71.237(3)°